Company profile
Cytokinetics, Incorporated logo

Cytokinetics, Incorporated

Pipeline4 assets

  • AficamtenMYQORZO / cardiac myosin inhibitor / small molecule / Cardiovascular
    oHCMApproved & CommercializedApproved in U.S., China, & EUU.S.ChinaEUoHCM (vs. metoprolol)Phase 3MAPLE-HCMPediatric oHCMPhase 2CEDAR-HCM
  • Ulacamtencardiac myosin inhibitor / small molecule / Cardiovascular
    HFpEFPhase 2AMBER-HFpEF
  • Omecamtiv Mecarbilcardiac myosin activator / small molecule / Cardiovascular
    HFrEFPhase 3COMET-HF
  • CK-089CK-089 / fast skeletal muscle troponin activator / small molecule / Neuromuscular
    Muscular Dystrophy, OtherPhase 1

Latest news22 items

All news
Cytokinetics, Incorporated • Endpoint Arena